Skip to content

A Clinical Study of Online Active Play Program With Adolescents

A Clinical Study of Online Active Play Program With Adolescents During COVID-19 Lockdown

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04618341
Enrollment
32
Registered
2020-11-05
Start date
2020-03-30
Completion date
2020-07-28
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

Adolescents, Online Active Revival Program

Brief summary

To assess the efficacy of an online, active play program (Revival Active Program) in reducing the symptoms of anxiety and depression in community-based adolescents,, a retrospective community based participatory research was conducted with 32 adolescents aged between 11-17 years old. Program was conducted during Covid-19 lockdown from March 2020 to June 2020 to support children and families in isolation.

Interventions

None listed

Sponsors

L.E.A.D
CollaboratorUNKNOWN
Aarogyam UK
CollaboratorOTHER
Revival Active
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years

Inclusion criteria

* Children at the online program for whole duration * indicating a symptom level of, at minimum, above mean on anxiety and/or depression on self-report measures * Parental consent before stating the program

Exclusion criteria

* Children at normal levels of mental health screening * Children who did not complete the intervention period

Design outcomes

Primary

MeasureTime frameDescription
DepressionChange from baseline depression at 6 weeksSeverity Measure for Depression child version was used to measure depression levels
AnxietyChange from baseline anxiety at 6 weeksScreen for Child Anxiety Related Disorders (SCARED) child version was used to assess anxiety levels.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026